تحميل...
Fasting during Ramadan: efficacy, safety, and patient acceptability of vildagliptin in diabetic patients
Diabetes management during Ramadan fasting is challenging to the physician in terms of minimizing the risk of hypoglycemia. As compared to oral hypoglycemic agents (OHAs) and sulfonylureas (SUs), which carry a higher and significant risk of hypoglycemia, newer antidiabetic agents such as dipeptidyl...
محفوظ في:
| الحاوية / القاعدة: | Diabetes Metab Syndr Obes |
|---|---|
| المؤلف الرئيسي: | |
| التنسيق: | Artigo |
| اللغة: | Inglês |
| منشور في: |
Dove Medical Press
2015
|
| الموضوعات: | |
| الوصول للمادة أونلاين: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4404947/ https://ncbi.nlm.nih.gov/pubmed/25931826 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/DMSO.S54683 |
| الوسوم: |
إضافة وسم
لا توجد وسوم, كن أول من يضع وسما على هذه التسجيلة!
|